Breakthrough · June 22, 2026
FDA Clears First Clinical Trial for New Multiple Sclerosis Remyelination Drug
Pheno Therapeutics' MS candidate receives FDA clearance to advance toward clinical trials, offering hope for multiple sclerosis pa...